SSA
ATRS

Schonfeld Strategic Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,847
Closed -$148K – 1770
2020
Q2 		$148K Buy
53,847
+28,847
+115% +$80.5K ﹤0.01% 1143
2020
Q1 		$59K Buy
+25,000
New +$85K ﹤0.01% 1045
2019
Q2 		– Sell
-23,600
Closed -$71K – 1339
2019
Q1 		$71K Buy
+23,600
New +$76.5K ﹤0.01% 996

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Schonfeld Strategic Advisors's ATRS Position: Q3 2020 in Review

Schonfeld Strategic Advisors sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 53,847 shares — an estimated $148K sold.

Schonfeld Strategic Advisors first reported a position in ATRS in Q1 2019 and held it in 3 quarters. The position peaked at $148K in Q2 2020. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

  • Schonfeld Strategic Advisors reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 53,847 Antares Pharma, Inc. shares in Q3 2020, an estimated $148K.
  • Schonfeld Strategic Advisors first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Antares Pharma, Inc. position peaked at $148K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.